These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838 [TBL] [Abstract][Full Text] [Related]
5. [Arterial complications of estrogen-progestogen contraception]. Jaillard J Ann Med Interne (Paris); 1983; 134(5):416-20. PubMed ID: 6651062 [TBL] [Abstract][Full Text] [Related]
7. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study. Hannaford PC; Kay CR Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Cole JA; Norman H; Doherty M; Walker AM Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834 [TBL] [Abstract][Full Text] [Related]
14. [Oral contraceptives: pharmacotherapy of normal women (author's transl)]. Bühler FR Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821 [TBL] [Abstract][Full Text] [Related]
15. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Tanis BC; Rosendaal FR Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494 [TBL] [Abstract][Full Text] [Related]
16. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858 [TBL] [Abstract][Full Text] [Related]
17. [Status of oral contraceptives as a risk factor in cerebrovascular diseases]. Auff E; Zeiler K; Holzner F; Wimmer S; Deecke L Wien Klin Wochenschr; 1986 May; 98(10):304-10. PubMed ID: 3727590 [TBL] [Abstract][Full Text] [Related]
18. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
19. [Major vascular complications during treatment with oral contraceptives and retrospective discovery of idiopathic hyperlipemia. 9 cases]. de Gennes JL; Turpin G; Truffert J Presse Med (1893); 1970 Mar; 78(12):541-6. PubMed ID: 5439189 [No Abstract] [Full Text] [Related]
20. [The role of age, smoking habits, and oral contraceptives in the frequency of myocardial infarction in young women (author's transl)]. Goldzieher JW Reproduccion; 1980; 4(1):21-7. PubMed ID: 7389993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]